Bioform Medical Inc - Current report filing (8-K)
January 31 2008 - 4:05PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of
1934
January
31, 2008
Date
of Report (date of earliest event reported)
BIOFORM
MEDICAL, INC.
(Exact
name of Registrant as specified in its charter)
Delaware
|
|
001-33791
|
|
39-1979642
|
(State
of incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S.
Employer
Identification
Number)
|
1875
South Grant Street, Suite 110
San
Mateo, California 94402
(Address
of principal executive offices)
(650)
286-4000
(Registrant’s
telephone number, including area code)
N/A
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR
230.425)
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR
240.14d-2(b))
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR
240.13e-4(c))
|
Item 2.02.
|
Results
of Operations and Financial
Condition.
|
On
January 31, 2008, BioForm Medical, Inc. (“BioForm”) issued a press release
announcing financial results for the
quarter
ended December 31, 2007, which is the Company’s second quarter of fiscal year
2008
.
A copy of the press release is furnished as Exhibit 99.1 to this Form
8-K.
This
information and the information contained in the press release shall not be
deemed “filed” for purposes of
Section 18
of the Securities Exchange Act of 1934, as amended, or otherwise subject to
the
liabilities of that Section.
The
information in this Current Report is not incorporated by reference into any
filings of BioForm made under the Securities
Act
of 1933, as amended, whether made before or after the date of this Current
Report, regardless of any general information
language
in the filing unless specifically stated so therein.
Item 9.01.
|
Financial
Statements and Exhibits.
|
(d)
Exhibits.
Exhibit No.
|
|
Description
|
99.1
|
|
Press
Release of BioForm Medical, Inc. dated as of January 31,
2008.
|
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
|
|
BioForm
Medical, Inc.
|
|
|
|
Date:
January 31, 2008
|
By:
|
/s/
Derek Bertocci
|
|
Derek
Bertocci
|
|
Chief
Financial Officer
|
Bioform Medical (MM) (NASDAQ:BFRM)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bioform Medical (MM) (NASDAQ:BFRM)
Historical Stock Chart
From Jul 2023 to Jul 2024